Knockdown of NEAT1 up-regulated the tumor suppressor miR-34c to inhibit cell proliferation, induce apoptosis, and cell cycle arrest via BCL-2 and cyclin D1 pathway, which elevated the sensitivity to DDP-induced chemotherapy for tumor regression. This evidence concerns the gene BCL2 and neoplasm.